The adenylate cyclase activator forskolin partially protects l929 cells against tumour necrosis factor-alpha-mediated cytotoxicity via a camp-independent mechanism

Cytokine

Volumn 19, Issue 5, 2002, Pages 250-258

  Uboldi, Alessandro D ^a   Savage, Nerina ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Dibutyryl cAMP 1,9 dideoxyforskolin DNA fragmentation forskolin TNF

Indexed keywords

1,9 DIDEOXYFORSKOLIN; ADENYLATE CYCLASE ACTIVATOR; BUCLADESINE; CYCLIC AMP; CYCLOSPORIN A; DNA FRAGMENT; FORSKOLIN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; ADENYLATE CYCLASE; CYCLOSPORIN;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; CELL LINE; CELL MEMBRANE PERMEABILITY; DRUG ANTAGONISM; HUMAN; METABOLISM; TIME;

ADENYLATE CYCLASE; CELL DEATH; CELL LINE; CELL MEMBRANE PERMEABILITY; CYCLIC AMP; CYCLOSPORINE; DNA FRAGMENTATION; FORSKOLIN; HUMANS; PENTOXIFYLLINE; THEOPHYLLINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036035438     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(02)91969-1     Document Type: Article

References (64)

1. Grooten J, Goossens V, Vanhaesebroeck B, Fiers W (1993) Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine 5:546-555.
2. Vercammen D, Vandenabeele P, Beyaert R, Declerq W, Fiers W (1997) Tumour necrosis factor-induced necrosis versus anti-fas-induced apoptosis in L929 cells. Cytokine 9:801-808.
3. Mirkina II, Mernenko OA, Satpaev DK, Karelin AA, Blishchenko EY (1996) Cytolytic processes induced by TNF in L929 and K562 differ in DNA fragmentation mechanisms. Immunol Lett 52:105-108.
4. Park DJ, Patek PQ (1998) Detergent and enzyme treatment of apoptotic cells for the observation of DNA fragmentation. BioTechniques 24:558-569.
5. Sánchez-Alcázar JA, Ruíz-Cabello J, Hernández-Muñoz I, Pobre PS, de la Torre P, Siles-Rivas E, García I, Kaplan O, Munoz-Yague MT, Solis-Herruzo JA (1997) Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death. J Biol Chem 272:30167-30177.
6. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem 267:5317-5323.
7. Hennet T, Richter C, Peterhans E (1993) Tumour necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem J 289:587-592.
8. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12:3095-3104.
9. Goossens V, Grooten J, De Vos K, Fiers W (1995) Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92:8115-8119.
10. Polla BS, Jacquier-Sarlin MR, Kantengwa S, Mariéthoz E, Hennet T, Russo-Marie F, Cossarizza A (1996) TNFα alters mito-chondrial membrane potential in L929 but not in TNFα-resistant L929.12 cells: relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity. Free Rad Res 25: 125-131.
11. Goossens V, Stange G, Moens K, Pipeleers D, Grooten J (1999) Regulation of tumor necrosis factor-induced, mitochondria-and reactive oxygen species-dependent cell death by the electron flux through the electron transport chain complex I. Antioxid Redox Signal 1:285-295.
12. Ko S, Kwok TT, Fung KP, Choy YM, Lee CY, Kong SK (2001) Tumour necrosis factor induced an early release of superoxide and a late mitochondrial membrane depolarization in L929 cells. Increase in the production of superoxide is not sufficient to mimic the action of TNF. Biol Signals Recept 10:326-335.
13. Hennet T, Bertoni G, Richter C, Peterhans E (1993) Expression of Bcl-2 protein enhances the survival of mouse fibro-sarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res 53:1456-1460.
14. Zoratti M, Szabo I (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241:139-176.
15. Ruggiero V, Johnson SE, Baglioni C (1987) Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell Immunol 107:317-325.
16. Suffys P, Beyaert R, Van Roy F, Fiers W (1988) Involvement of a serine protease in tumour-necrosis-factor-mediated cytotoxicity. Eur J Biochem 178:257-265.
17. Suffys P, Beyaert R, Van Roy F, Fiers W (1987) Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of arachi-donic acid metabolism. Biochem Biophys Res Commun 149: 735-743.
18. Neale ML, Fiera RA, Matthews N (1988) Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology 64:81-85.
19. Agarwal S, Drysdale B-E, Shin HS (1988) Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. J Immunol 140:4187-4192.
20. Matthews N, Neale ML, Jackson SK, Stark JM (1987) Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62:153-155.
21. Yamauchi N, Kuriyama H, Watanabe N, Neda H, Maeda M, Niitsu Y (1989) Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 49: 1671-1675.
22. Hepburn A, Boeynaems J-M, Fiers W, Dumont JE (1987) Modulation of tumor necrosis factor-α cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism. Biochem Biophys Res Commun 149:815-822.
23. Beyaert R, Su3ys P, Van Roy F, Fiers W (1990) Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. FEBS Lett 262:93-96.
24. Messmer UK, Winkel G, Briner VA, Pfeilschifter J (1999) Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomeru-lar endothelial cells upstream of caspase 3 activation. Br J Pharmacol 127:1633-1640.
25. Wong GHW, Goeddel DV (1988) Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science 242:941-944.
26. Wong GHW, Elwell JH, Oberley LW, Goeddel DV (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931.
27. Kizaki M, Sakashita A, Karmakar A, Lin C-W, Koeffer PH (1993) Regulation of manganese superoxide dismutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor. Blood 82:1142-1150.
28. Liu Z-G, Hsu H, Goeddel DV, Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NFκB activation prevents cell death. Cell 87: 565-576.
29. Beg AA, Baltimore D (1996) An essential role for NFκB in preventing TNF-α-induced cell death. Science 274:782-784.
30. Wang C-y, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NFκB. Science 274:784-787.
31. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-α-induced apoptosis by NFκB. Science 274:787-789.
32. Opipari AW Jr, Ming Hu H, Yabkowitz R, Dixit VM (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 267:12424-12427.
33. Jäättelä M, Mouritzen H, Elling F, Bastholm L (1996) A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 156:1166-1173.
34. Heyninck K, Denecker G, de Valck D, Fiers W, Beyaert R (1999) Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20. Anticancer Res 19:2863-2868.
35. Jäättelä M, Wissing D, Bauer PA, Li GC (1992) Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J 11:3507-3512.
36. Jäättelä M (1993) Overexpression of major heat shock portein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J Immunol 151:4286-4294.
37. Parvathenani LK, Buescher ES, Chacon-Cruz E, Beebe SJ (1998) Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J Biol Chem 273:6736-6743.
38. Webster CR, Anwer MS (1998) Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 27:1324-1331.
39. Polte T, Schröder H (1998) Cyclic AMP mediates endo-thelial protection by nitric oxide. Biochem Biophys Res Commun 251:460-465.
40. Orlov SN, Thorin-Trescases N, Dulin NO, Dam T-V, Fortuno MA, Tremblay J, Hamet P (1999) Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3. Cell Death Diff 6: 661-672.
41. Niwa M, Hara A, Kanamori Y, Matsuno H, Kozawa O, Yoshimi N, Mori H, Uematsu T (1999) Inhibition of tumor necrosis factor-alpha induced neutrophil apoptosis by cyclic AMP: Involvement of caspase cascade. Eur J Pharmacol 371:59-67.
42. Inanami O, Yoshito A, Takahashi K, Hiraoka W, Kuwabara M (1999) E3ects of BAPTA-AM and forskolin on apoptosis and cytochrome c release in photosensitized Chinese hamster V79 cells. Photochem Photobiol 70:650-655.
43. Li J, Yang S, Billiar R (2000) Cyclic nucleotides suppress tumour necrosis factor α-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 275:13026-13034.
44. Boucher M-J, Duchesne C, Lainé J, Morisset J, Rivard N (2001) cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. Biochem Biophys Res Commun 285:207-216.
45. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW (1995) Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor-α, and ceramide. Cancer Res 55:991-994.
46. Laouar A, Glesne D, Huberman E (1999) Involvement of protein kinase C-beta and ceramide in tumour necrosis factor-alpha-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J Biol Chem 274:23526-23534.
47. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
48. Joost HG, Habberfield AD, Simpson IA, Laurenza A, Seamon KB (1988) Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action. Mol Pharmacol 33:449-453.
49. Crompton M, Ellinger H, Costi A (1988) Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255:357-360.
50. Broekemeier KM, Dempsey ME, Pfeiffer DR (1989) Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264: 7826-7830.
51. Igbavboa U, Zwizinski CW, Pfeiffer DR (1989) Release of mitochondrial matrix proteins through a Ca2+-requiring, cyclosporin-sensitive pathway. Biochem Biophys Res Commun 161:619-625.
52. Bernardi P, Veronese P, Petronilli V (1993) Modulation of the mitochondrial cyclosporine A-sensitive permeability transition pore. J Biol Chem 268:1005-1010.
53. Broekemeier KM, Pfeiffer DR (1995) Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochem 34:16440-16449.
54. Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P (1996) Interactions of cyclophilin with mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J Biol Chem 271:2185-2192.
55. Pastorino JG, Chen ST, Tafani M, Snyder JW, Farber JL (1998) The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 273: 7770-7775.
56. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Rémy R, Xie Z-H, Reed JC, Kroemer G (1998) The permeability transition pore complex: A target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 187: 1261-1271.
57. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HLA, Prévost M-C, Xie Z, Matsuyama S, Reed JC, Kroemer G (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027-2031.
58. Pfeuffer T, Metzger H (1982) 7-O-hemisuccinyl-deacetyl forskolin-Sepharose: A novel affinity support for purification of adenylate cyclase. FEBS Lett 146:369-375.
59. Laurenza A, Khandelwal Y, De Souza NJ, Rupp RG, Metzger H, Seamon KB (1987) Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Mol Pharmacol 32:133-139.
60. Semmler J, Gebert U, Eisenhut T, Moeller J, Schönharting MM, Alléra A, Endres S (1993) Xanthine derivatives: Comparison between suppression of tumour necrosis factor-α-production and inhibition of cAMP phosphodiesterase activity. Immunology 78:520-525.
61. Belloc F, Jaloustre C, Dumain P, Lacombe F, Lenoble M, Boisseau MR (1995) Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol 25(Suppl 2):S71-S74.
62. Belizario JE, Tilly JL, Sherwood SW (1993) Caffeine potentiates the lethality of tumour necrosis factor in cancer cells. Br J Cancer 67:1229-1235.
63. Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Diff 6:99-104.
64. Laurenza A, McHugh Sutkowski E, Seamon KB (1989) Forskolin: A specific stimulator of adenylate cyclase or a diterpene with multiple sites of action? Trends Pharm Sci 10:442-447.